Current Status of COVID-19 Vaccines Rollout Nationwide: March 2022 Update for the Attorney General Community

On March 24, the U.S. reached 255.1 million persons (76.8% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 217.3 million persons (65.4% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…

Read More →

Current Status of COVID-19 Vaccines Rollout Nationwide: February 2022 Update for the Attorney General Community

On February 18, the U.S. reached 252.5 million persons (76.1% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 214.5 million persons (64.6% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…

Read More →

Crisis Standards of Care During the COVID-19 Pandemic: Legal and Policy-Related Issues

As various regions of the the United States experienced COVID-19-related surges in cases, hospitals and other providers have reported scarcity in essential resources (e.g., available intensive care unit (ICU) beds, personnel, treatments, and personal protective equipment (PPE)). In response, providers as well as state, territorial, and local health authorities have prepared and/or implemented crisis standards…

Read More →

Current Status of COVID-19 Vaccines Rollout Nationwide: January 2022 Update for the Attorney General Community

On January 18, the U.S. reached 249.4 million persons (75.1% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 209.3 million persons (63.0% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…

Read More →

Current Status of COVID-19 Vaccines Rollout Nationwide: December 2021 Update for the Attorney General Community

On December 20, the U.S. reached 241.6 million persons (72.8% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 203.9 million persons (61.4% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…

Read More →

Public Health and Legal Implications of Flexibilities for Substance Use Treatment During and After the COVID-19 Pandemic

The webinar provides the attorney general community and other stakeholders with an update on increased flexibilities in treatment delivery (e.g., telehealth services) for substance use disorder treatment during and beyond the COVID-19 pandemic, highlights specific policy and legal considerations. Specifically, the webinar provides the following: An overview of the federal-level policies that allow for flexibilities…

Read More →

An Update on Housing and Student Loan Issues, and the Return to the Office

Federal and state COVID-related consumer protections from mortgage foreclosures and from residential and student loan defaults were in flux due to ending moratoriums and extensions, as well as legal cases challenging the validity of those protections. Panelists discuss the status of these protections and share their insights on what challenges face consumers and attorney general…
note: This content requires site login.

Read More →

Current Status of COVID-19 Vaccines Rollout Nationwide: November 2021 Update for the Attorney General Community

On November 30, the U.S. reached 232.8 million persons (70.1% of the total U.S. population) having received at least one dose of a COVID-19 vaccine and 196.8 million persons (59.3% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine or two shots of either…

Read More →

Current Status of COVID-19 Vaccines Rollout Nationwide: October 2021 Update for the Attorney General Community

On October 22, the U.S. reached over 611.0 million total COVID-19 vaccine doses administered with 219.6 million persons (66.2% of the total U.S. population) having received at least one dose and 189.9 million persons (57.2% of the total U.S. population) being fully vaccinated (i.e., having received either one shot of the Johnson & Johnson/Janssen vaccine…

Read More →

COVID-19 and Its Impacts on Substance Use and Overdose

Provisional Centers for Disease Control & Prevention (CDC) data show that U.S. drug overdose deaths increased by 30% in 2020 from the prior year, reaching an all-time high. Increases in overdose deaths were reported for synthetic opioids (primarily fentanyl), natural or semi-synthetic opioids (e.g., prescription pain medications), psychostimulants (e.g., methamphetamine), and cocaine. In many ways,…

Read More →